According to a study by Nyati et al. (21), in GBS the expression of IL-1, TNF-α, IL-6, and IL-10 was upregulated during the active progressive GBS phase in a case-control study, that included 65 GBS patients (21). The gene discussed is IL1B; the disease is Guillain-Barre syndrome.